Your browser doesn't support javascript.
loading
Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures.
Oliveras-Cañellas, Núria; Moreno-Navarrete, José María; Lorenzo, Paula M; Garrido-Sánchez, Lourdes; Becerril, Sara; Rangel, Oriol; Latorre, Jèssica; de la Calle Vargas, Elena; Pardo, Maria; Valentí, Victor; Romero-Cabrera, Juan L; Oliva-Olivera, Wilfredo; Silva, Camilo; Diéguez, Carlos; Villarroya, Francesc; López, Miguel; Crujeiras, Ana B; Seoane, Luisa-Maria; López-Miranda, José; Frühbeck, Gema; Tinahones, Francisco José; Fernández-Real, José-Manuel.
Afiliação
  • Oliveras-Cañellas N; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona 17007, Spain.
  • Moreno-Navarrete JM; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.
  • Lorenzo PM; Department of Medical Sciences, School of Medicine, University of Girona, Girona 17003, Spain.
  • Garrido-Sánchez L; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • Becerril S; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona 17007, Spain.
  • Rangel O; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.
  • Latorre J; Department of Medical Sciences, School of Medicine, University of Girona, Girona 17003, Spain.
  • de la Calle Vargas E; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • Pardo M; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • Valentí V; Epigenomics in Endocinology and Nutrition Group, Epigenomics Unit, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela 15706, Spain.
  • Romero-Cabrera JL; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • Oliva-Olivera W; Servicio de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Virgen de la Victoria, Universidad de Málaga, Málaga 29590, Spain.
  • Silva C; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • Diéguez C; Obesity Area, Clínica Universidad de Navarra, University of Navarra, Pamplona 31009, Spain.
  • Villarroya F; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • López M; Nutrigenomics, Metabolic Syndrome Department, Servicio de Medicina Interna, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba 14004, Spain.
  • Crujeiras AB; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona 17007, Spain.
  • Seoane LM; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.
  • López-Miranda J; Department of Medical Sciences, School of Medicine, University of Girona, Girona 17003, Spain.
  • Frühbeck G; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid 28029, Spain.
  • Tinahones FJ; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona 17007, Spain.
  • Fernández-Real JM; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.
J Clin Endocrinol Metab ; 109(1): e145-e154, 2023 Dec 21.
Article em En | MEDLINE | ID: mdl-37560997
ABSTRACT
CONTEXT Climate change and global warming have been hypothesized to influence the increased prevalence of obesity worldwide. However, the evidence is scarce.

OBJECTIVE:

We aimed to investigate how outside temperature might affect adipose tissue physiology and metabolic traits.

METHODS:

The expression of genes involved in thermogenesis/browning and adipogenesis were evaluated (through quantitative polymerase chain reaction) in the subcutaneous adipose tissue (SAT) from 1083 individuals recruited in 5 different regions of Spain (3 in the North and 2 in the South). Plasma biochemical variables and adiponectin (enzyme-linked immunosorbent assay) were collected through standardized protocols. Mean environmental outdoor temperatures were obtained from the National Agency of Meteorology. Univariate, multivariate, and artificial intelligence analyses (Boruta algorithm) were performed.

RESULTS:

The SAT expression of genes associated with browning (UCP1, PRDM16, and CIDEA) and ADIPOQ were significantly and negatively associated with minimum, average, and maximum temperatures. The latter temperatures were also negatively associated with the expression of genes involved in adipogenesis (FASN, SLC2A4, and PLIN1). Decreased SAT expression of UCP1 and ADIPOQ messenger RNA and circulating adiponectin were observed with increasing temperatures in all individuals as a whole and within participants with obesity in univariate, multivariate, and artificial intelligence analyses. The differences remained statistically significant in individuals without type 2 diabetes and in samples collected during winter.

CONCLUSION:

Decreased adipose tissue expression of genes involved in browning and adiponectin with increased environmental temperatures were observed. Given the North-South gradient of obesity prevalence in these same regions, the present observations could have implications for the relationship of the obesity pandemic with global warming.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Adiponectina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Adiponectina Idioma: En Ano de publicação: 2023 Tipo de documento: Article